Breast Cancer Stage II Clinical Trial
Official title:
Optimizing Surgical Decisions in Young Adults With Breast Cancer
The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions. Participants will complete surveys within 1 week of the surgical consult and 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.
Primary objectives: - To test the effectiveness of the CONSYDER decision support tool on reducing decisional conflict prior to breast cancer surgery. - To evaluate the implementation of and mechanisms of use for CONSYDER. Secondary Objectives: - To determine the impact of CONSYDER on decision-making preferences, breast cancer knowledge, treatment goals and preferences, anxiety, decisional regret, and self-efficacy in communication. Exploratory Objectives: - To explore whether CONSYDER impacts surgical choice. OUTLINE: This is a multi-site cluster randomized trial using a stepped wedge design. Approximately 800 women will be recruited at 4 study sites (Weill Cornell Medicine, Yale Cancer Center, Dana-Farber Cancer Institute, Duke Cancer Institute), including network affiliate sites, over an approximate 30-month period. All sites will have a 6-month "run-in" period where patients will not be sent CONSYDER. The 6-month blocks may be extended if recruitment targets are not met. Sites will be randomized to begin delivery of CONSYDER to all newly diagnosed women, age ≤44, with Stage 0-III breast cancer as part of routine clinical care; young women will have access to the website whether or not they consent to research study participation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
| Recruiting |
NCT03270072 -
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
|
||
| Terminated |
NCT03723863 -
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy
|
N/A | |
| Completed |
NCT00393341 -
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
|
N/A | |
| Recruiting |
NCT05558722 -
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04180579 -
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT03879577 -
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
|
Phase 2 | |
| Withdrawn |
NCT03058939 -
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05877859 -
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
|
||
| Recruiting |
NCT05296746 -
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
|
Phase 2 | |
| Withdrawn |
NCT05774886 -
Implantable Microdevice for TNBC - Pilot Study
|
Phase 1 | |
| Completed |
NCT01599039 -
Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema
|
N/A | |
| Unknown status |
NCT01352494 -
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
|
Phase 2 | |
| Completed |
NCT03578627 -
Stress and Immunity Breast Cancer Project
|
N/A | |
| Not yet recruiting |
NCT05724758 -
Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery
|
||
| Active, not recruiting |
NCT03766009 -
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
|
N/A | |
| Recruiting |
NCT05406531 -
The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT03609047 -
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT05898789 -
Virtual Rehabilitation for Cancer Survivors
|
N/A | |
| Recruiting |
NCT06006806 -
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
|
N/A |